Skip to main content

Peer Review reports

From: An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy

Original Submission
5 Aug 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
23 Sep 2021 Reviewed Reviewer Report
28 Sep 2021 Reviewed Reviewer Report
28 Oct 2021 Author responded Author comments - Timothy J. Yeatman
Resubmission - Version 3
28 Oct 2021 Submitted Manuscript version 3
2 Nov 2021 Author responded Author comments - Timothy J. Yeatman
Resubmission - Version 4
2 Nov 2021 Submitted Manuscript version 4
5 Nov 2021 Author responded Author comments - Timothy J. Yeatman
Resubmission - Version 5
5 Nov 2021 Submitted Manuscript version 5
9 Nov 2021 Author responded Author comments - Timothy J. Yeatman
Resubmission - Version 6
9 Nov 2021 Submitted Manuscript version 6
15 Dec 2021 Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
28 Feb 2022 Editorially accepted
10 Mar 2022 Article published 10.1186/s12885-022-09344-3

You can find further information about peer review here.

Back to article page